TG THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
TG THERAPEUTICS, INC. (TGTX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $19.21 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2011-11-14
- TG THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2011-09-30 was $5.60K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2011-09-30 | $5.60K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $19.21K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $13.61K 10-Q/A · filed 2011-09-14 | |||
| 2010-12-31 | $217.48K 10-Q · filed 2011-11-14 | |||
| 2009-12-31 | $353.44K 10-Q · filed 2011-11-14 | |||
| 2008-12-31 | $463.89K 10-Q · filed 2011-11-14 | |||
| 2007-12-31 | $1.44M 10-Q · filed 2011-11-14 | |||
| 2006-12-31 | $1.68M 10-Q · filed 2011-11-14 | |||
| 2005-12-31 | $87.14K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |